NCT04245683 Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population
| NCT ID | NCT04245683 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bassett Healthcare |
| Condition | Rectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2020-02-01 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2020-02-01 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational research study. Patients with rectal cancer can choose different courses of treatment. This study will follow these patients over the course of approximately six years, depending on their treatment. Patients will be monitored through clinic visits and survey assessments to see how they do, how they feel regarding their treatment choices, and their outcomes. The surveys will analyze the impact of the patients' treatment choices, as well as patient adherence, in a rural setting.
Eligibility Criteria
Inclusion Criteria: For a patient to be considered eligible for this study, ALL of the following conditions must be met: 1. Age 18 or greater 2. ECOG PS 0-2 3. Stage II or III, newly diagnosed, biopsy proven, rectal cancer 4. No prior treatment for rectal cancer 5. No prior pelvic radiotherapy 6. Willing to undergo study related testing and monitoring after treatment 7. Women of childbearing potential must rule out pregnancy within 2 weeks prior to registration with a blood test or urine study 8. Women must not be pregnant or breastfeeding 9. Able to provide informed consent Exclusion Criteria: Patients are NOT considered eligible for this study if any of the following conditions apply: 1. Patients with metastatic disease 2. Patients that are not candidates for surgery 3. Patients that refuse neoadjuvant treatment
Contact & Investigator
Eric Bravin, MD
PRINCIPAL INVESTIGATOR
Bassett Healthcare
Frequently Asked Questions
Who can join the NCT04245683 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04245683 currently recruiting?
Yes, NCT04245683 is actively recruiting participants. Contact the research team at jennifer.victory@bassett.org for enrollment information.
Where is the NCT04245683 trial being conducted?
This trial is being conducted at Cooperstown, United States.
Who is sponsoring the NCT04245683 clinical trial?
NCT04245683 is sponsored by Bassett Healthcare. The principal investigator is Eric Bravin, MD at Bassett Healthcare. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.